The short-term outlook is bullish for Ipca Laboratories. The stock has been going gradually higher over the last one month. The recent price action indicates that the stock is getting good buyers around ₹1,450.

Below this, ₹1,410 will be the next support. Moving average cross overs on the daily chart also strengthens the bullish case.

It indicates that the downside could be limited from here. Ipca Laboratories share price can rise to ₹1,640 in the coming weeks.

Traders can buy Ipca Laboratories shares now at ₹1,532. Accumulate on dips at ₹1,510. Keep the stop-loss at ₹1,460.

Video Credit: Businessline

Trail the stop-loss up to ₹1,555 as soon as the stock goes up to ₹1,575. Revise the stop-loss higher to ₹1,580 and ₹1,610 when the price touches ₹1,605 and ₹1,620 respectively. Exit the long positions at ₹1,640.

(Note: The recommendations are based on technical analysis. There is risk of loss in trading.)

Published on March 12, 2026